Method of reducing craving in mammals
OwnerVicki L. Coffin, Paul W. Glueinventors
Life of this patent
Estimating the term…
Abstract
A method of reducing cravings in a mammal to food or an addictive substance is disclosed. The method comprises administering to the mammal an effective amount of a D1/D5 antagonist or a D1/D5 partial agonist alone or in combination with other specified CNS compounds.
Claims20
A method for reducing cravings to food or an addictive substance in a mammal comprising administering to the mammal an anti-craving effective amount of a D1/D5 antagonist, a D1/D5 partial agonist or mixtures thereof.
A method for reducing cravings to food or an addictive substance in a mammal comprising administering to the mammal an anti-craving effective amount of a compound selected from a D1/D5 antagonist, a D1/D5 partial agonist and mixtures thereof, and a compound selected from the class consisting of:
- A. anti-obesity compounds;
- B. serotonin receptor agonists and antagonists;
- C. antipsychotics/anxiolytics;
- D. antidepressants;
- E. dopaminergic agonists;
- F. anticonvulsants/mood stimulants;
- G. cocaine-like agonists;
- H. cocaine catalytic antibodies;
- and
- I. alcohol antagonist drugs.
A method for reducing food cravings in a mammal comprising administering to the mammal an anti-craving effective amount of SCH 39166.
A method for reducing nicotine cravings in a mammal comprising administering to the mammal an anti-craving effective amount of SCH 39166.
A method for reducing alcohol cravings in a mammal comprising administering to the mammal an anti-craving effective amount of SCH 39166
A kit to reduce cravings to food or an addictive substance comprising a compound selected from the class consisting of a D1/D5 antagonist, a D1/D5partial agonist and mixtures thereof in combination with one or more compounds selected from the class consisting of:
- A. anti-obesity compounds;
- B. serotonin receptor agonists and antagonists;
- C. antipsychotics/anxiolytics;
- D. antidepressants;
- E. dopaminergic agonists;
- F. anticonvulsants/mood stimulants;
- G. cocaine-like agonists;
- H. cocaine catalytic antibodies;
- and
- I. alcohol antagonist drugs.
Dependencies are inferred from the claim text.